Treatment of toenail onychomycosis. Prescribing terbinafine to every patient with the condition would be expensive

BMJ. 1999 Oct 30;319(7218):1197.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antifungal Agents / economics*
  • Antifungal Agents / therapeutic use
  • Drug Costs
  • Foot Dermatoses / drug therapy
  • Humans
  • Naphthalenes / economics*
  • Naphthalenes / therapeutic use
  • Onychomycosis / drug therapy
  • Onychomycosis / economics*
  • Terbinafine

Substances

  • Antifungal Agents
  • Naphthalenes
  • Terbinafine